NCT06171893

Brief Summary

For women that experience angina symptoms with underlying vascular spasm as the cause, stress has an aggravating role. Coping with stress is therefore included as an important pillar in dealing with this chronic disease, see the European Association of Percutaneous Cardiovascular Interventions (EACPI) consensus document on INOCA. In practice, stress management focuses on informing and identifying the role stress plays in their lives. A potential stress management tool: "Wavy" aims to help users manage stress more consciously through biofeedback. This research focuses on the effectiveness of stress management applications. The hypothesis is that the app will help to avoid the trigger stress as much as possible and thus reduce the burden of disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
117

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2022

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 15, 2023

Completed
Last Updated

January 19, 2024

Status Verified

January 1, 2024

Enrollment Period

5 months

First QC Date

November 28, 2023

Last Update Submit

January 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • seattle angina questionnaire

    A valid, reproducible, responsive instrument for assessing disease-specific health status among patients with coronary artery disease

    10 weeks

Secondary Outcomes (5)

  • VAS score on pain

    10 weeks

  • Heart rate variability

    10 weeks

  • Perceived stress score

    10 weeks

  • SF-36

    10 weeks

  • Symptom diary

    10 weeks

Study Arms (1)

Control vs intervention

EXPERIMENTAL

Each subject will take part in a four-week control period, followed by a four-week intervention period.

Behavioral: Wavy stress application

Interventions

The intervention consists of the application named Wavy. Wavy uses artificial intelligence and the user's feedback to detect stress increasingly more efficient over time. This provides not only real-time feedback on an individual's stress level but also helps the patient to calm down using music guided relaxation. It does so with a music filter, allowing the participant to listen to music where the stress level determines the quality of the music. Thus, relaxing is rewarded by improving the experience. In this process, implicit learning is used to establish a habit of getting better at recognising increased stress levels and getting familiar with reducing stress levels more and more effectively.

Control vs intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female.
  • Aged 18-70 (upper-limit, because of increased comorbidities and potential difficulties with using the technology).
  • Suffering from chronic angina pectoris.
  • Diagnosed with INOCA, documented within 2 years, with a coronary angiogram and an abnormal coronary function test (CFT), indicative of either epicardial or microvascular vasospasms.
  • Daily usage of a smartphone with an operating system equal to or higher than Android 5.0 (Lollipop) or IOS 10.0.
  • Signed written informed consent.
  • Excluded criteria:
  • She is not available for the assigned research period of approximately 10 weeks from May 2021 till October 2022. The application can be used during the planned holidays.
  • She is unable to participate in the stress-reducing exercise, e.g., due to hearing problems.
  • A language barrier is present.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Radboud universty medical center

Nijmegen, Gelderland, 6525GA, Netherlands

Location

Maastricht UMC

Maastricht, Limburg, 6229 HX, Netherlands

Location

VieCuri

Venlo, Limburg, 5900BX, Netherlands

Location

Catharina Hospital

Eindhoven, North Brabant, 5623 EJ, Netherlands

Location

Elisabeth-TweeSteden Hospital

Tilburg, North Brabant, 5042AD, Netherlands

Location

Maasstad Hospital

Rotterdam, South Holland, 3079 DZ, Netherlands

Location

MeSH Terms

Conditions

IschemiaCoronary VasospasmSpasmAngina, StableAngina Pectoris, Variant

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsCoronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsAngina PectorisChest PainPainAngina, Unstable

Study Officials

  • Suzette Elias-Smale, dr.

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: A single-arm, controlled, multicentre trial, will be conducted to validate to study objective. The study is divided into five iterative substudies of which the first four are aimed towards improving the application, based on the quantitative data from the smartwatch and the qualitative feedback of the users whilst also validating the recent version through assessing the interim study outcomes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2023

First Posted

December 15, 2023

Study Start

August 1, 2022

Primary Completion

December 23, 2022

Study Completion

December 31, 2022

Last Updated

January 19, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations